| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
* To whom correspondence should be addressed. E-mail: m.maggi{at}dfc.unifi.it.
Spontaneously hypertensive rats (SHR) are characterized by impaired erectile function and by overactivity of the pro-contractile RhoA/Rho-kinase (RhoA/ROCK) pathway, as compared to their normotensive counterpart, Wistar Kyoto rats. By measuring intracavernous pressure/mean arterial pressure (ICP/MAP) ratio after electrostimulation of the cavernous nerve, we confirmed these findings and showed that also responsiveness to sildenafil (25 mg/kg by oral gavage) is hampered in SHR. A two-week treatment with atorvastatin (5 and 30 mg/kg) improved sildenafil-induced ICP/MAP increase and normalized RhoA and ROCK2 over-expression (qRT-PCR) in SHR corpora cavernosa (CC). Conversely, other genes, nNOS, eNOS and PDE5, were unaffected. In human foetal smooth muscle cells derived from CC (hfPSMC), atorvastatin inhibited RhoA membrane translocation and ROCK activity as well as RhoA-dependent biological functions, like cell migration and proliferation. Atorvastatin effect on migration was dose-dependently rescued by geranylgeranyl pyrophosphate, suggesting the involvement of RhoA geranylgeranylation. In hfPSMC, atorvastatin decreased the expression of RhoA-dependent genes as ROCK2, desmin, alfa-smooth muscle actin, SM22alfa and myocardin. In contrast to atorvastatin, elocalcitol, a vitamin D analogue, which also interferes with RhoA activation in SHR bladder, was unable to restore penile responsiveness to sildenafil. In conclusion, atorvastatin, but not elocalcitol, ameliorates sildenafil-induced penile erections in SHR rats, likely by interfering with RhoA/ROCKs signaling within the penis.
Key words: Erectile Dysfunction
Phosphodiesterase 5 inhibitor
RhoA-dependent genes
SHR rat model
human penile smooth muscle cells
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |